S-1 combined preoperative neoadjuvant Multimodality therapy with Radiation and Irinotecan for locally advanced rectal cancer.
Phase of Trial: Phase I
Latest Information Update: 01 Aug 2016
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Irinotecan
- Indications Rectal cancer
- Focus Adverse reactions
- Acronyms SAMRAI-1
- 18 Jul 2016 Status changed from active, no longer recruiting to completed.
- 18 Feb 2014 Planned End Date changed from 1 Jan 2014 to 31 May 2015 as reported by University Hospital Medical Information Network - Japan.
- 22 Mar 2013 Planned end date changed from 1 Jan 2013 to 1 Jan 2014 as reported by University Hospital Medical Information Network - Japan.